Yarchoan Talks Research Directions in Fibrolamellar Carcinoma

Season 6 Episode 6  ·  Nov 04, 2021, 09:11 PM

Headliner
Share
Subscribe

Dr. Yarchoan underscores the unique characteristics of fibrolamellar carcinoma, treatment options for these patients, and ongoing research efforts to expand the limited paradigm in this disease.

Share
Subscribe
Next
Tagawa Breaks Down FGFR Testing and the Use of Erdafitinib in Bladder Cancer
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air